Literature DB >> 29874124

miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma.

Fangfang Tao1, Xinxin Tian2,3, Shanming Ruan4, Minhe Shen4, Zhiqian Zhang3,5.   

Abstract

Accumulating evidence has indicated that microRNAs (miRNAs) play an important role in the occurrence and progression of ovarian cancer (OC). However, the function of miRNAs implicated in OC remains unclear. This study investigated the potential role of miR-211 in OC. Gene Expression Omnibus database analysis indicated that miR-211 expression was significantly down-regulated in OC tissues compared with normal specimens. In addition, miR-211 overexpression apparently inhibited proliferation, migration, xenograft growth, and induced apoptosis in HEY-T30 and SKOV3 cells. Moreover, PHF19, a component of the polycomb group of proteins, was found to be a direct target of miR-211 based on the luciferase reporter assay and Western blot analysis. Consistently, survival analysis indicated that high PHF19 expression was associated with shorter survival time in patients with OC. Importantly, silence of PHF19 reduced proliferation, induced cell cycle arrest, promoted apoptosis, suppressed migration, and inhibited xenograft growth in SKOV3 cells. Restoration of PHF19 expression markedly reversed the inhibitory effect of miR-211 on OC. Moreover, our results indicate that the long noncoding RNA MALAT1 could sponge miR-211 as a competing endogenous RNA and potentially up-regulate PHF19 expression, thus facilitating the OC progression. These findings suggest that the MALAT1/miR-211/PHF19 axis may act as a key mediator in OC and provide new insight into the prevention of this disease.-Tao, F., Tian, X., Ruan, S., Shen, M., Zhang, Z. miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma.

Entities:  

Keywords:  MALAT1; MiR-211; PHF19; ceRNA; ovarian cancer

Year:  2018        PMID: 29874124     DOI: 10.1096/fj.201800495RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

1.  Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.

Authors:  Selin Oncul; Paola Amero; Cristian Rodriguez-Aguayo; George A Calin; Anil K Sood; Gabriel Lopez-Berestein
Journal:  RNA Biol       Date:  2019-12-17       Impact factor: 4.652

2.  Comprehensive analysis of the long non-coding RNA-associated competitive endogenous RNA network reveals novel prognostic biomarkers in Wilms' tumor.

Authors:  Zifeng Liu; Wenbo Zhao; Yuqing Ren; Chang Liu; Xun Liu; Jian Xiao
Journal:  Oncol Lett       Date:  2020-03-31       Impact factor: 2.967

Review 3.  MALAT1: a potential biomarker in cancer.

Authors:  Zhi-Xing Li; Qiong-Ni Zhu; Hai-Bo Zhang; Yang Hu; Guo Wang; Yuan-Shan Zhu
Journal:  Cancer Manag Res       Date:  2018-12-06       Impact factor: 3.989

4.  LINC01118 Modulates Paclitaxel Resistance of Epithelial Ovarian Cancer by Regulating miR-134/ABCC1.

Authors:  Cong Shi; Min Wang
Journal:  Med Sci Monit       Date:  2018-12-06

5.  FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG.

Authors:  Shuo Cao; Jian Zheng; Xiaobai Liu; Yunhui Liu; Xuelei Ruan; Jun Ma; Libo Liu; Di Wang; Chunqing Yang; Heng Cai; Zhen Li; Ziyi Feng; Yixue Xue
Journal:  J Exp Clin Cancer Res       Date:  2019-01-28

6.  Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro.

Authors:  Su Hu; Li Xu; Lihua Li; Dongdong Luo; Hailin Zhao; Dan Li; Biao Peng
Journal:  Onco Targets Ther       Date:  2018-12-21       Impact factor: 4.147

7.  miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer.

Authors:  Tianzhen Wang; Dapeng Hao; Shucai Yang; Jianhui Ma; Weiwei Yang; Yuanyuan Zhu; Mingjiao Weng; Xiang An; Xuefei Wang; Yafei Li; Di Wu; Jing Tang; Chao Yang; Yan He; Lei Zhang; Xiaoming Jin; Guangyu Wang; Zhiwei Li; Tongsen Zheng; Hongxue Meng; Yukuan Feng; Xiaobo Li
Journal:  Cell Death Dis       Date:  2019-06-24       Impact factor: 8.469

8.  LncRNA MALAT1/MiR-145 Adjusts IL-1β-Induced Chondrocytes Viability and Cartilage Matrix Degradation by Regulating ADAMTS5 in Human Osteoarthritis.

Authors:  Chengyao Liu; Shan Ren; Shifeng Zhao; Yandong Wang
Journal:  Yonsei Med J       Date:  2019-11       Impact factor: 2.759

9.  Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.

Authors:  Lufeng Zheng; Qianqian Guo; Chenxi Xiang; Shijia Liu; Yuzhang Jiang; Lanlan Gao; Haiwei Ni; Ting Wang; Qiong Zhao; Hai Liu; Yingying Xing; Yaohui Wang; Xiaoman Li; Tao Xi
Journal:  J Hematol Oncol       Date:  2019-03-04       Impact factor: 17.388

10.  PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells.

Authors:  Payal Jain; Cecilia Ballare; Enrique Blanco; Pedro Vizan; Luciano Di Croce
Journal:  Elife       Date:  2020-03-10       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.